| 000 | 01094 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516224216.0 | ||
| 264 | 0 | _c20150521 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1476-5454 | ||
| 024 | 7 |
_a10.1038/eye.2014.167 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOrssaud, C | |
| 245 | 0 | 0 |
_aResponse to Dr Soleimani. _h[electronic resource] |
| 260 |
_bEye (London, England) _cNov 2014 |
||
| 300 |
_a1385 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 |
_aCytosine _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOcular Hypotension _xchemically induced |
| 650 | 0 | 4 |
_aOrganophosphonates _xadverse effects |
| 650 | 0 | 4 |
_aPupil Disorders _xetiology |
| 700 | 1 | _aWermert, D | |
| 700 | 1 | _aRoux, A | |
| 700 | 1 | _aLaccourreye, O | |
| 700 | 1 | _aSors, H | |
| 700 | 1 | _aRoche, O | |
| 700 | 1 | _aDufier, J L | |
| 773 | 0 |
_tEye (London, England) _gvol. 28 _gno. 11 _gp. 1385 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/eye.2014.167 _zAvailable from publisher's website |
| 999 |
_c24041371 _d24041371 |
||